Exclusive: Hashgraph lands IBM marketplace listing for AI-agent identity tool
Source: Investing.com

The Hashgraph Group secured an IBM Cloud Catalog listing for its IDTrust AI-agent identity software and signed a global partnership with IBM, including Silver Partner status and an Embedded Solution Agreement. The deal gives THG access to IBM's enterprise customer base as demand grows for authentication of autonomous AI agents; Gartner expects 40% of enterprise applications to embed task-specific agents by end-2026, versus less than 5% in 2025. IDTrust, built on Hedera's distributed ledger, is already deployed with a European telecom operator for verified caller identity.
Analysis
The economic value to IBM is initially indirect: marketplace distribution raises the stickiness of IBM Cloud and watsonx workloads if agent governance becomes a procurement gate rather than a point-security feature. The more material read-through is validation that enterprise buyers may prefer identity controls embedded at deployment, favoring platform vendors with existing regulated-industry channels. IBM can monetize through cloud consumption, implementation services and partner-led sales, but a small partner listing is not yet a revenue catalyst sufficient to alter estimates or the multiple.
Over the next 1-3 months, the relevant catalyst is whether IBM identifies AI-agent governance as a named demand driver in bookings, remaining performance obligations, or consulting pipeline commentary. Incumbent identity vendors—Okta (OKTA), CyberArk (CYBR), Microsoft (MSFT) and Palo Alto Networks (PANW)—have far larger installed bases and could bundle comparable agent-identity capabilities, limiting standalone vendor pricing. Conversely, successful deployments in telecom, financial services or healthcare would reinforce an emerging security-spend category and benefit identity/security leaders more than IBM alone.
The contrarian view is that “agent identity” adoption may lag agent deployment: enterprises can initially constrain agents through permissions, human approval layers and existing IAM rather than procure a new distributed-ledger-based identity stack. A durable category requires interoperability across major agent frameworks, audit acceptance and demonstrable reduction in fraud or compliance losses. Absent disclosed customer wins, contract value, or usage-driven cloud consumption, this is a strategic optionality signal rather than a tradable earnings event.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
Ticker Sentiment
Key Decisions for Investors
- No standalone directional IBM trade on this announcement; wait for the next earnings call for quantified AI-security bookings, cloud-consumption uplift, or consulting pipeline conversion. Reassess long IBM only if management ties agent governance to guidance or backlog growth.
- Maintain a 6-12 month watchlist long CYBR or OKTA versus short IGV only after either vendor reports agent-security attach rates or material identity-cloud acceleration; category spend is more likely to accrue to incumbents with privileged-access and enterprise identity distribution.
- For IBM holders, use a break below the post-earnings support level combined with weaker-than-guided software growth as thesis falsification; the partnership does not provide downside protection against core software or consulting execution risk.
- Monitor MSFT, PANW, OKTA and CYBR product announcements for native agent credentialing, authorization and audit features. A bundled offering from these vendors would validate demand but diminish the commercial significance of niche marketplace applications.
More News
- Meta's standoff with Amazon over Muse could be a sign of things to come
- Bond yields spike and stocks drop — plus, why Boeing is bucking the trend
- Anthropic Could Join the Nasdaq-100 Only 15 Trading Days After Its IPO, Just Like SpaceX Did
- History rhymes for Meta, and our plan for Micron ahead of earnings
- United Therapeutics at Bernstein forum: growth bets widen
- Meta's Muse AI agent weighs on financial industry as investors fear competition to human advisors